Yang Lu
Nuclear Medicine · Houston, TXNPI 1982850657
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Blue Earth Diagnostics at 38.3% of the total. Reporting peaked in 2021 at $1,715 and has fallen 86.2% since, to $237 in 2024.
Across 10 payments — averaging $348.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Blue Earth Diagnostics$1K
- Clovis Oncology, Inc.$810
- Progenics Pharmaceuticals, Inc.$450
- GE HealthCare$440
- AstraZeneca$237
- Advanced Accelerator Applications$110
- plus $101 from 1 others
Across 52 payments — averaging $12,063 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Progenics Pharmaceuticals, Inc.$622K
- Blue Earth Diagnostics$5K
What the payments were for
- Consulting fees$1,72550%
- Speaking & faculty fees$67719%
- Travel & lodging$66419%
- Food & beverage$41812%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Blue Earth Diagnostics | 3 | $1,335 |
| Clovis Oncology, Inc. | 2 | $810 |
| Progenics Pharmaceuticals, Inc. | 1 | $450 |
| GE HealthCare | 1 | $440 |
| AstraZeneca | 1 | $237 |
| Advanced Accelerator Applications | 1 | $110 |
| United Imaging Healthcare North America LLC | 1 | $101 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,483 in reported general payments places this provider in the 85th percentile of 37 nuclear medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in Houston
- Warren MooreHouston$13K
- Beth ChasenHouston$12K
- Lesley FlyntHouston$8K
- Devaki Shilpa SurasiHouston$7K
- Simone KrebsHouston$3K
- Guofan XuHouston$878
- Patrick FordHouston$370
- Hubert ChuangHouston$263
- Nghi NguyenHouston$187
- Daniel LeeHouston$167
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.